Portfolia, a venture capital firm focused on diverse investment opportunities, has closed its third femtech fund at $4.15 million, with contributions from 249 limited partners.
Founded in 2014 by Trish Costello, former co-founder of the Kauffman Fellows Program, Portfolia manages approximately $70 million across 26 funds, with investment focuses including women’s health, active aging, sustainability, and other sectors. Women make up 90% of the firm’s limited partners.
The new femtech fund will focus on companies addressing various stages of women’s health. “Our goal is to change the way women’s healthcare is invested in,” Costello explained in an interview with Femtech Insider. “Specifically, investments will focus on companies addressing all stages and experiences of womanhood, such as mental health, pregnancy, pregnancy loss, fertility, menopause, aging, and more.”
Previous investments from Portfolia’s femtech funds include Maven Clinic, the first women’s health unicorn, and EverlyWell, a health testing unicorn. “Despite the fact that women make 80% of the healthcare decisions for themselves and their families, women’s health is underfunded in the U.S. and other countries around the globe,” notes Costello. “The market is forecasted to be worth $48B by 2027 and is a mature enough space to generate significant returns.”
The launch of FemTech Fund III builds on Portfolia’s track record of investing in women’s health since 2018, when they created their first femtech-focused fund. The firm’s approach combines return potential with impact, focusing on solutions their largely female investor base wants to see in the market.
